9th World Congress on Breast Cancer and Therapies: March 2019

Thursday, March 28, 2019

Early detection Saves Life : Breast Cancer Summit 2019

Time-restricted eating may prevent tumor growth

Researchers have already identified obesity as a risk factor for cancer, so some doctors recommend reducing caloric intake to help prevent tumors. However, a new study now finds that prevention may be less about how many calories you consume and more about when you eat your meals.

The increase in the risk of breast cancer is particularly high in women who are overweight and have been through menopause.

Now, a new study suggests that rather than changing what they eat to prevent tumor growth, a person may benefit from simply timing their meals differently.

For more information, Do attend

9th World Congress on Breast Cancer & Therapies

(Breast Cancer Summit 2019)

#april 29-30, #kyoto, Japan

Theme: Advancement in breast cancer and Helping at every step of the journey

Tuesday, March 26, 2019

World Congress on Breast Cancer & Therapies

How destroying a tumor promoter could lead to new cancer treatments

Scientists have cracked a cell mechanism that drives tumor formation in most types of cancer. This finding could lead to much-needed new therapies for cancer, including the hard-to-treat triple-negative breast cancer.

The discovery concerns the molecular activity of the tumor suppressor protein p53. This protein sits inside the nucleus of the cell and protects the cell's DNA from stress. It has acquired the nickname "guardian of the genome" for this reason.

However, mutated forms of p53, which are common in cancer, behave differently than regular p53. Instead of protecting the cell, they can take on oncogenic, or tumor-promoting, properties and become active drivers of cancer.

Previous studies had already shown that p53 mutations are more stable than their nonmutant counterparts and can accumulate until they eclipse them in the nucleus. However, the mechanism behind the stability of p53 mutations remained unclear.

Now, researchers from the School of Medicine and Public Health at the University of Wisconsin-Madison have unpicked the stabilizing mechanism, and they suggest that it offers a promising target for new cancer treatments. Their findings feature in the journal Nature Cell Biology.

The stabilizing process involves two molecules: the enzyme PIPK1-alpha and its "lipid messenger" PIP2. Between them, they appear to regulate the function of p53.

"Although p53 is one of the most commonly mutated genes in cancer," says co-lead researcher and study author Vincent L. Cryns, who is a professor of medicine, "we still do not have any drugs that specifically target p53."

9th World Congress on Breast Cancer & Therapies

#april 29-30, 2019 #kyoto, Japan

Wednesday, March 20, 2019

Early Bird Ending...

9th World Congress on Breast Cancer & Therapies
(Breast Cancer Summit 2019)
#April 29-30, 2019
#kyoto, Japan

Early bird ending by 22nd of March
#registersoon #register
#before 22 March 2019
avail best prices

Monday, March 18, 2019

Track 2: Reconstruction of Breast Cancer

9th World Congress on Breast Cancer & Therapies
(Breast Cancer Summit 2019)
#april 29-30, 2019
#kyoto #japan

Advancement in breast cancer and Helping at every step of the journey
Track 2: Reconstruction of Breast Cancer

You may have had near to have an extirpation, either as a result of you’ve been diagnosed with carcinoma oared at terribly high risk of developing it within the future. If so, your doctor might have told you regarding choices to build your breast or breasts — a surgery known as breast reconstruction. Typically, breast reconstruction takes place throughout or shortly when extirpation, and in some cases, lumpectomy. Breast reconstruction can also be done several months or maybe years when extirpation or excision. throughout reconstruction, an operating surgeon creates a breast form victimization a synthetic implant (implant reconstruction), a flap of tissue from another place on your body (autologous reconstruction), or both.

Friday, March 15, 2019

Track 1 : Types of Breast Cancer

9th World Congress on Breast Cancer & Therapies
(Breast Cancer Summit 2019)
#april 29-30, 2019
#Kyoto #Japan
#Advancement in Breast cancer and Helping at every step of the journey

TYPES OF BREAST CANCER

There area unit many sorts of carcinoma. the foremost common varieties area unit ductal malignant neoplastic disease in place, invasive ductal malignant neoplastic disease, and invasive lobe malignant neoplastic disease. The type of carcinoma is set by the precise cells within the breast that area unit affected. Most breast cancers area unit carcinomas. Carcinomas area unit tumors that begin within the animal tissue cells that line organs and tissues throughout the body. Sometimes, a good additional specific term is employed. as an example, most breast cancers area unit a sort of malignant neoplastic disease known as glandular cancer, that starts in cells that form up glands (glandular tissue). Breast adenocarcinomas begin within the ducts (the milk ducts) or the lobules (milk-producing glands).

The type of breast cancer is determined by the specific cells in the breast that are affected. Most breast cancers are carcinomas. Carcinomas are tumors that start in the epithelial cells that line organs and tissues throughout the body. Sometimes, an even more specific term is used. For example, most breast cancers are a type of carcinoma called adenocarcinoma, which starts in cells that make up glands (glandular tissue). Breast adenocarcinomas start in the ducts (the milk ducts) or the lobules (milk-producing glands). There are other, less common, types of breast cancers, too, such as sarcomas, phyllodes, Paget disease, and angiosarcomas which start in the cells of the muscle, fat, or connective tissue.